GE Healthcare Launches High Content Analysis Award
News May 04, 2010
GE Healthcare, a unit of General Electric Company, announces the launch of the first annual GE Healthcare HCA Award. Supported by BioTechniques, the award recognizes the outstanding contribution of HCA to scientific understanding and celebrates its positive impact on data quality and quantity, and in transforming the efficiency of research and discovery.
“HCA has transformed the way in which researchers investigate biological systems by increasing the number of scientific questions they can ask whilst simultaneously decreasing the time taken to achieve results,” said Dr Nick Thomas, Principal Scientist, Cell Technologies, GE Healthcare: “The latest developments in instrumentation, software and applications allow a depth and breadth of biological analysis that would have seemed impossible only a few years ago.”
Entries are welcomed from scientists using the IN Cell Analyzer 1000, 2000 or 3000. Entries will be reviewed by an expert scientific panel comprising Dr. Joe Trask, Head of Cellular Imaging Core at Hamner Institutes of Health Services, Dr. Nick Thomas, Principal Scientist, Cell Technologies, GE Healthcare and Dr. Patrick Lo, Associate Editor, BioTechniques.
The HCA Award will be presented to the author of the winning entry during one of the following conferences; ASCB 2010, Neuroscience 2010, CHI HCA 2011, SBS 2011, or AACR 2011. The winner will also have an opportunity to present a poster based on their work.
Concept Life Sciences appoints New Group Programme Manager and US Head of SalesNews
Key leadership appointments support integration of the Group and expansion in the US market.READ MORE
Blood-vessel-on-a-chip Provides Insight into Novel Anti-Inflammatory Drug CandidateNews
Researchers have discovered that synthetic APC-mimicking small molecules called “parmodulins” provide anti-inflammatory and anti-thrombotic protection to endothelial cells on par with APC’s without interfering with normal blood clotting and coagulation, making them attractive new drug candidates.READ MORE
Brian Berridge Set to Manage National Toxicology ProgramNews
The National Toxicology Program (NTP) has named Brian Berridge, D.V.M., Ph.D., as its new Associate Director. Berridge, formerly of GlaxoSmithKline, will oversee day-to-day operations as NTP coordinates toxicology research and testing across nine different federal agencies.READ MORE